St. Jude Medical is releasing in the U.S. a new MR-compatible, upgradeable, and recharge-free spinal cord stimulation (SCS) system following FDA approval. The Proclaim Elite SCS for chronic pain is programmable using an Apple iPad mini tablet by connecting to it via Bluetooth. That means that therapy can be carefully adjusted to each patient, while when new software features come out they can be uploaded to the device to keep it up to date without repeat surgery.
“St. Jude Medical has a legacy of consistently advancing spinal cord stimulation therapy options to our ensure chronic pain patients are receiving innovative, patient-centric devices and optimal therapy to manage their chronic pain,” said Allen Burton, M.D., medical director of neuromodulation at St. Jude Medical. “The new St. Jude Medical Proclaim Elite system bridges the gap between today’s state-of-the-art therapies and tomorrow’s groundbreaking innovations for chronic pain. The wireless platform is based on the latest Apple technologies making it upgradeable to new therapies for the future. With a discreet, hassle-free trial system and a simple permanent implant procedure, this pioneering platform can improve both the patient’s chronic pain and overall therapy experience.”
More from St. Jude Medical…